North America Cellulite Treatment Market 2023-2030
Market Outlook
Triton Market Research’s report reckons that the cellulite treatment market in North America is set to advance with a compound annual growth rate of 9.58% over the forecasting years 2023-2030. Canada and the United States are gauged in the region.
The high prevalence of obesity is expected to drive the market’s growth in Canada. As per estimates, the number of people diagnosed with obesity is expected to rise owing to unhealthy lifestyle choices. This will further elevate the demand for cosmetic procedures to enhance appearance. Moreover, the increase in the geriatric population has also surged the demand for aesthetic treatments like cellulite reduction. In this regard, non-invasive and minimally invasive treatments have significantly backed the expansion of the cellulite treatment market.
Likewise, the high obesity rates have compelled people to opt for various treatments in the US. The availability of minimally invasive procedures has significantly increased the number of patients opting for cellulite treatments. Hence, the growing beauty consciousness and advanced treatments widen the overall scope and growth of the cellulite treatment market across the United States.
Competitive Outlook
The established companies in the cellulite treatment market consist of AbbVie Inc, Bausch Health Companies Inc, Johnson & Johnson, Galderma SA, and Endo International Plc.
1. North America Cellulite Treatment Market - Summary
2. Industry Outlook
2.1. Parent Market Analysis
2.2. Impact Analysis On The Cellulite Treatment Market
2.2.1. Covid-19 Impact On The Cellulite Treatment Market
2.2.2. Ukraine-russia War Impact On The Cellulite Treatment Market
2.3. Porter’s Five Forces Analysis
2.3.1. Threat Of New Entrants
2.3.2. Threat Of Substitutes
2.3.3. Bargaining Power Of Buyers
2.3.4. Bargaining Power Of Suppliers
2.3.5. Threat Of Competitive Rivalry
2.4. Market Maturity Analysis
2.5. Industry Components
2.5.1. Research And Development
2.5.2. Manufacturing Of Product
2.5.3. Distribution
2.5.4. Post-sales Monitoring
2.6. Regulatory Framework
2.7. Key Buying Impact Analysis
2.7.1. Price
2.7.2. Brand Name
2.7.3. Usability
2.8. Key Market Strategies
2.8.1. Collaborations
2.8.2. Product Launches
2.8.3. Mergers & Acquisitions
2.8.4. Business Divestitures & Expansions
2.9. Market Drivers
2.9.1. Growing Prevalence Of Obesity
2.9.2. Rapidly Growing Medical Tourism Sector
2.9.3. Rising Demand For Aesthetic Procedures
2.10. Market Challenges
2.10.1. Lack Of Knowledge Regarding Cellulite Treatment
2.10.2. High Price Of Advanced Cellulite Treatment
2.10.3. Risks Associated Post-treatment
2.11. Market Opportunities
2.11.1. Rising Beauty Consciousness
2.11.2. Increasing Trend Of Anti-cellulite Massage
2.11.3. Growing Demand For Minimally Invasive And Non-invasive Procedures
2.11.4. Rising Popularity Of Radiofrequency Therapy For Cellulite Treatment
2.11.5. Advancements In Technologies And New Product Launches
2.12. Analyst Perspective
3. North America Cellulite Treatment Market – By Cellulite Type
3.1. Soft Cellulite
3.2. Hard Cellulite
3.3. Edematous Cellulite
4. North America Cellulite Treatment Market – By Procedure Type
4.1. Non-invasive
4.2. Minimally Invasive
4.3. Topical
5. North America Cellulite Treatment Market – By End-user
5.1. Hospitals
5.2. Clinics And Beauty Centers
5.3. Other End-users
6. North America Cellulite Treatment Market – By Country Outlook
6.1. Country Analysis
6.1.1. United States
6.1.1.1. United States Cellulite Treatment Market Forecast & Prospects